Literature DB >> 10086962

Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.

D E Newby1, R A Wright, C Labinjoh, C A Ludlam, K A Fox, N A Boon, D J Webb.   

Abstract

BACKGROUND: Effective endogenous fibrinolysis requires rapid release of tissue plasminogen activator (tPA) from the vascular endothelium. Smoking is a known risk factor for arterial thrombosis and myocardial infarction, and it causes endothelial dysfunction. We therefore examined the effects of cigarette smoking on substance P-induced tPA release in vivo in humans. METHODS AND
RESULTS: Blood flow and plasma fibrinolytic factors were measured in both forearms of 12 smokers and 12 age- and sex-matched nonsmokers who received unilateral brachial artery infusions of substance P (2 to 8 pmol/min). In both smokers and nonsmokers, substance P caused dose-dependent increases in blood flow and local release of plasma tPA antigen and activity (P<0.001 for all) but had no effect on the local release of plasminogen activator inhibitor type 1. Compared with nonsmokers, increases in forearm blood flow (P=0.03) and release of tPA antigen (P=0.04) and activity (P<0.001) caused by substance P were reduced in smokers. The area under the curve for release of tPA antigen and activity decreased by 51% and 53%, respectively.
CONCLUSIONS: Cigarette smoking causes marked inhibition of substance P-induced tPA release in vivo in humans. This provides an important mechanism whereby endothelial dysfunction may increase the risk of atherothrombosis through a reduction in the acute fibrinolytic capacity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086962     DOI: 10.1161/01.cir.99.11.1411

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  78 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study.

Authors:  Amy S Shah; Dana Dabelea; Jennifer W Talton; Elaine M Urbina; Ralph B D Agostino; R Paul Wadwa; Santica Marcovina; Richard F Hamman; Stephen R Daniels; Lawrence M Dolan
Journal:  J Pediatr       Date:  2014-03-27       Impact factor: 4.406

3.  Tobacco Smoking Associated With Increased Anastomotic Disruption Following Pancreaticoduodenectomy.

Authors:  Noah S Rozich; Alessandra Landmann; Casey S Butler; Morgan M Bonds; Laura E Fischer; Russell G Postier; Katherine T Morris
Journal:  J Surg Res       Date:  2018-08-31       Impact factor: 2.192

Review 4.  Pleiotropic effects of statins: moving beyond cholesterol control.

Authors:  Paul J Garcia
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

Review 5.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

6.  Current but not past smoking increases the risk of cardiac events: insights from coronary computed tomographic angiography.

Authors:  Rine Nakanishi; Daniel S Berman; Matthew J Budoff; Heidi Gransar; Stephan Achenbach; Mouaz Al-Mallah; Daniele Andreini; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Victor Y Cheng; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo Cury; Augustin Delago; Martin Hadamitzky; Jörg Hausleiter; Gudrun Feuchtner; Yong-Jin Kim; Philipp A Kaufmann; Jonathon Leipsic; Fay Y Lin; Erica Maffei; Gianluca Pontone; Gilbert Raff; Leslee J Shaw; Todd C Villines; Allison Dunning; James K Min
Journal:  Eur Heart J       Date:  2015-02-08       Impact factor: 29.983

7.  Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

Authors:  Antonio Tello-Montoliu; Vanessa Roldán; Vicente E Climent; Francisco Sogorb; Gregory Y H Lip; Francisco Marín
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

8.  Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations.

Authors:  M S Mähönen; P McElduff; A J Dobson; K A Kuulasmaa; A E Evans
Journal:  Tob Control       Date:  2004-09       Impact factor: 7.552

Review 9.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

Review 10.  Medical management of stable coronary atherosclerosis.

Authors:  P Pellicori; P Costanzo; A C Joseph; A Hoye; S L Atkin; J G F Cleland
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.